Finance

Lists
CTHRQ:OTCMKTS
Charles & Colvard Ltd
USD 0,0011
0,00%
(0,00) 1D
23 Sep., 15:28:51 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CTHRQ...
Mkt. cap
4,92 k
Avg. vol.
9,77 k
Volume
0,00
52-wk high
USD 0,14
52-wk low
USD 0,00
Beta
1,63
Shares outstanding
4,47 m
No. of employees
24
Mkt. cap
4,92 k
Avg. vol.
9,77 k
Volume
0,00
52-wk high
USD 0,14
52-wk low
USD 0,00
Beta
1,63
Shares outstanding
4,47 m
No. of employees
24
News stories
From web sources and news partners
Profile
Charles & Colvard, Ltd., is a publicly traded American company that distributes and manufactures jewelry, founded in 1995 by Charles Eric Hunter under the name C3 Inc., and then run by his brother Jeff Hunter until 2000. The company changed its name to Charles & Colvard in 1999. The company employs 63 people full-time, and generated $32.4 million in revenue during the year ending June 30, 2019, up from $27.91 million in the previous year. Charles & Covard was the first company to produce and sell synthetic moissanite, under U.S. patent US5723391 A, first filed by C3 Inc., North Carolina. Their gemstones are made from silicon carbide crystals, supplied under an exclusive agreement from Cree Inc. since 2014. In June 2019 the company netted $10 million from a secondary public offering. In March 2020, the company was notified that they were at risk of being delisted on NASDAQ, as their share price had been consistently below $1. Don O'Connell was announced CEO in May 2020, taking over after Suzanne T. Miglucci's resignation. The announcement came days after reporting their quarterly earnings, which included a $5.3 million writeoff. Wikipedia
About Charles & Colvard Ltd
CEODon O'Connell
Employees24
Founded1995
HeadquartersMorrisville, Noord-Carolina, Verenigde State van Amerika
SectorLuxury goods
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Jun. 2023
Sep. 2024
Des. 2024
Mrt. 2025
Revenue
-
3,23 m
4,63 m
4,05 m
Cost of goods sold
-
2,23 m
3,12 m
3,12 m
Cost of revenue
-
2,23 m
3,12 m
3,12 m
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
-
3,14 m
4,04 m
2,90 m
Operating expense
-
3,14 m
4,04 m
2,90 m
Total operating expenses
-
5,37 m
7,17 m
6,02 m
Operating income
-
-2,14 m
-2,54 m
-1,97 m
Other non operating income
-
-
-
-
EBT including unusual items
-
-2,13 m
-2,54 m
-1,97 m
EBT excluding unusual items
-
-2,13 m
-2,54 m
-1,97 m
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-
-2,13 m
-2,54 m
-1,97 m
Net profit margin
-
-65,98%
-54,79%
-48,73%
Earnings per share
-
-
-
-
Interest and investment income
-
43,64 k
38,11 k
16,14 k
Interest expense
-
-38,54 k
-35,62 k
-21,10 k
Net interest expenses
-
5,10 k
2,49 k
-4,96 k
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-1,92 m
-2,32 m
-1,75 m
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google-programme